Noliterax (Indapamide, Perindopril Arginine)

Indapamide, the active ingredient in Noliterax, is a diuretic (thiazide‑like) and ACE inhibitor combination presented as an oral tablet for oral use. It is indicated for the management of hypertension in adult patients.

GNH USA supplies Noliterax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Noliterax is an antihypertensive medication that acts on blood pressure regulation pathways. - Hypertension: lowers systolic and diastolic blood pressure in patients with elevated readings. - Essential hypertension: provides sustained control of primary high blood pressure. - High blood pressure: contributes to reduced cardiovascular risk by maintaining target pressures.

Noliterax may cause a range of adverse reactions, most of which are mild to moderate in severity.

Common Side Effects: - Dizziness: feeling light‑headed, especially after standing. - Headache: mild to moderate intensity. - Cough: dry, persistent throat irritation. - Fatigue: general tiredness or lack of energy. - Increased urination: more frequent need to void. - Electrolyte imbalance: changes in potassium or sodium levels.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue, or throat. - Severe hypotension: markedly low blood pressure causing faintness. - Renal impairment: worsening kidney function. - Hyperkalemia: elevated potassium concentration in blood. - Neutropenia: reduced white blood cell count. - Hepatic dysfunction: abnormal liver enzyme elevations.

Before initiating Noliterax, clinicians should consider several safety factors. - Blood pressure monitoring: check regularly to avoid excessive lowering. - Renal function assessment: evaluate serum creatinine and eGFR. - Electrolyte surveillance: monitor potassium and sodium levels. - Caution in diabetes: watch for changes in glucose control. - Avoid in severe hepatic impairment: limited data support use. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Noliterax can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Potassium‑sparing diuretics: risk of hyperkalemia. - Aliskiren in diabetic patients: additive renin‑angiotensin blockade. - Lithium: increased lithium levels and toxicity. - NSAIDs: may blunt antihypertensive effect and impair renal function. - ACE inhibitor with other ACE inhibitors or ARBs: heightened risk of renal dysfunction.

Moderate Interactions (Monitor Closely): - Thiazide‑type diuretics: additive electrolyte disturbances. - Other antihypertensives: may cause excessive blood pressure drop. - Diuretics causing dehydration: monitor volume status. - Antidiabetic agents: potential enhancement of hypoglycaemia. - Antimicrobials (e.g., trimethoprim): may increase potassium levels.